We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Healthcare Ent. | HCEG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.50 | 20.50 |
| Top Posts |
|---|
Posted at 17/8/2011 23:45 by willib2 Zapa.As I said to you once before. You have been well and truly ZAPPED, you should have listened to me. Mark30. Even now you are still making errors. HEG should be HCEG. |
Posted at 21/7/2011 15:21 by willib2 Mark30.How lucky is that. Hceg the company that sold (Or rather had stock of) the magic brew EBIOX gets wound up just 2 days before I made a bundle on BYOT which has a magic brew that actually sells. |
Posted at 24/6/2011 09:59 by johnny felopez BPRG/MDX/HCEG - must be my turn for some luck sooner or later? If only I had anything worthwhile left! |
Posted at 24/2/2011 10:11 by willib2 fft.Where on earth are you posting from. Hope you dont have a heart condition while awaiting a reply. HCEG had a couple of consolidations, and considerably more huge write offs. In fact the write offs were MASSIVELY more than any turnover they ever achieved. If ever there was a reason for AIM to tighten the rules, this was one of them. They supposedly had the best management team ever and for many tears this thread was entertained by a vibrant group of supposed knowledgeable investors who couldnt see the wood for the trees. Needless to say the person who touted it most suddenly vanished, a salutory lesson to any investor. You could possibly use it against CGT on other positive share dealings, but you would have to check that out. |
Posted at 24/2/2011 04:59 by fft I was going through some old boxes this morning and discovered a share certificate (in my name) dated 21-Mar-2003 for 20,000 HCEG.Looking today, it appears that it has gone bust, but i notice there has been a share consolidation (250:1) a couple of years ago, so does that mean i have 80 shares now. And looking at the chart, it appears that back in 2005 it was worth 30 or 40 quid a share. is that right ? could i have sold my 20k HCEG for nearly a million ? surely not. what have i missed (or what is advfn displaying wrongly !) |
Posted at 27/10/2010 08:49 by johnny felopez An interesting point raised on Meldex board re. possibility of offsetting a loss against income:then link to this 'Deducting losses from your income', towards bottom of page. Anyone have any thoughts as to the possibility of doing this with HCEG? TIA |
Posted at 24/8/2010 18:41 by willib2 Substp/Mark30.A GOLDEN OPPORTUNITY. Rememember when that Warrington based airline wanted to use a disinfectant cleaner on their aircraft and Hceg had multi gallons of it on the warehouse shelves at Warrinmgton and unbelievably missed the opportunity. Well Warrington Trust have just become the only trust to refuse IVF treatment due to cost. |
Posted at 12/8/2010 15:44 by substp And let's not forget RSL with its US FDA approval and being manufactured by Catheter Research Inc . You know ..... the one that is looking for someone to market it .......RSL 27% owned by HCEG with 200,00 redeemable shares Hello Willib ! |
Posted at 07/4/2010 09:29 by johnny felopez Wind taken out of my sales when having read the good news I checked my account to see that HCEG have managed to turn £3k into 8 shares worth £2.40 !!That's magic! |
Posted at 07/4/2010 08:10 by pre back up towards 80p from here now?? Wow!!Fertiligent medical device receives FDA approval TIDMHCEG RNS Number : 7916J Healthcare Enterprise Group PLC 07 April 2010 ? 07 April 2010 Healthcare Enterprise Group PLC (AIM: HCEG) ("Healthcare Enterprise" or the "Group") Fertiligent medical device receives FDA approval Healthcare Enterprise, an international healthcare group, is pleased to announce that Reproductive Sciences Limited ("RSL" or "the Company"), in which it holds a 27% interest, has reported that its Fertiligent artificial insemination device has received formal approval from the US Food and Drugs Administration ("FDA") for its sale in the United States. Highlights: · FDA approval received · European CE approval for the final model received in March 2010 · Manufacturing & assembly agreement signed with Catheter Research, Inc of Indianapolis, Indiana, USA · Discussions underway to appoint US and international distributors with the aim of commencing sales later in 2010 RSL holds the worldwide sales and marketing rights to Fertiligent's products, including the "Evie" device. HCEG has contributed management oversight to RSL, with direct private investment from funders including Nigel Wray. RSL has focussed on Fertiligent's "Evie" product, a high quality, low cost intrauterine sperm pump to help assist infertile couples conceive. From initial trials conducted in Germany and Israel, Fertiligent offers infertile couples an enhanced intrauterine insemination success rate and the chance of avoiding invasive and costly artificial reproductive techniques such as in vitro fertilisation. The Company, RSL, owns 45% of the issued capital in the Israeli Fertiligent Limited company, with options to increase that holding to 78% of the fully diluted capital. RSL also owns the exclusive, worldwide sales & marketing rights to the Israeli Fertiligent company's products. Lyndon Gaborit, Executive Deputy Chairman of Healthcare Enterprise, commented: "We are delighted that this critical milestone has been achieved for the Fertiligent 'Evie' medical device. FDA approval, and the recently received CE approval for the final production version, significantly reduces risk and paves the way for a roll out of this exciting product around the world. Women's reproductive health is a significant and increasing market and this new product, which provides couples with a low cost alternative to existing reproduction methods such as IVF, should, we believe, find good market acceptance with associated returns to RSL's investors, including HCEG." For further information, please contact: +------------------- | Healthcare Enterprise Group PLC | | | | Lyndon Gaborit | Tel: +44 (0)20 7680 | | | | 3649 | | +------------------- | Daniel Stewart & Company plc | Tel + 44 (0)20 7776 6550 | | Andrew Edwards/Emma Earl | | | | | +------------------- | Bishopsgate Communications | | | | Robyn Samuelson / Giang Nguyen | Tel: +44 (0)20 7562 | | | | 3355 | | | | | | +------------------- Note to Editors Healthcare Enterprise Healthcare Enterprise Group PLC (HCEG) is a healthcare investment group which invests in synergistic products and services within the healthcare industry. It currently has two main investments: · Ebiox Limited - Patented decontamination and disinfectant products that are safe and alcohol free but substantially more effective than conventional methods at destroying embedded microorganisms. The Ebiox range includes hand hygiene products, surface disinfectants and products to clean and decontaminate surgical instruments. HCEG owns 20% of Ebiox Limited. · Reproductive Sciences Limited - Innovative slow release pump for intrauterine insemination, proven to significantly enhance pregnancy success rates. HCEG owns 27% of the Company. This information is provided by RNS The company news service from the London Stock Exchange END MSCUGUUWCUPUGBQ |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
